anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

All filtered slides

Global slide inventory for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Corpus coverage

319,975 slides

319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.

Total slides
319,975
Described
319,974
Pending
1

Slide type composition

dynamicclickable
Slide type

Showing 319,974 described slides — 100.0% of 319,975 rendered pages

+Context & problem43,76713.7% · 6,592 docs+Data & charts72,62022.7% · 8,666 docs+Meta & navigation45,93614.4% · 9,739 docs+Recommend & act67,04121.0% · 9,324 docs+Cases & evidence31,2569.8% · 6,067 docs+Frameworks2,1230.7% · 1,232 docs+Appendix35,68211.2% · 6,614 docs+Other21,5496.7% · 5,566 docs

Tile area is proportional to slide count. Click a category to open its subtype map.

all document kinds · all orientations
18 30 60

Slide collection

223,741-223,800 of 319,975

filter-aware
18
D-Wave | Investor Presentation Deck | 28 slidesD-Wave | Investor Presentation Deck | 28 slides · D-Wave
Pitch deck Investor relations Beat · ActionLoop · Cost Of Inaction1 hit
19
The slide uses a growth curve visualization to link product releases to market expansion.D-Wave | Investor Presentation Deck | 28 slides · D-Wave
Pitch deck Investor relations Beat · ActionLoop · Cost Of Inaction1 hit
20
D-Wave | Investor Presentation Deck | 28 slidesD-Wave | Investor Presentation Deck | 28 slides · D-Wave
Pitch deck Investor relations Beat · ActionLoop · Cost Of Inaction1 hit
21
The slide uses a split-panel layout to contrast current capabilities with future advancements.D-Wave | Investor Presentation Deck | 28 slides · D-Wave
Pitch deck Investor relations Beat · ActionLoop · Cost Of Inaction1 hit
22
Uses a Venn diagram to illustrate the three pillars of quantum system performance.D-Wave | Investor Presentation Deck | 28 slides · D-Wave
Pitch deck Investor relations Beat · ActionLoop · Cost Of Inaction1 hit
23
The slide uses a scientific publication as social proof and a log-log chart to demonstrate performance scaling.D-Wave | Investor Presentation Deck | 28 slides · D-Wave
Pitch deck Investor relations Beat · Action1 hit
24
D-Wave | Investor Presentation Deck | 28 slidesD-Wave | Investor Presentation Deck | 28 slides · D-Wave
Pitch deck Investor relations Beat · Action1 hit
25
The slide uses a circular graphic to emphasize the 99% uptime metric.D-Wave | Investor Presentation Deck | 28 slides · D-Wave
Pitch deck Investor relations Beat · Action1 hit
26
The slide uses a US map graphic to emphasize the 220+ US granted patents.D-Wave | Investor Presentation Deck | 28 slides · D-Wave
Pitch deck Investor relations Beat · Action1 hit
27
Includes footnotes regarding YOY growth consistency and ELOC liquidity.D-Wave | Investor Presentation Deck | 28 slides · D-Wave
Pitch deck Investor relations Beat · Action1 hit
28
Slide 28 of the deck.D-Wave | Investor Presentation Deck | 28 slides · D-Wave
Pitch deck Investor relations Beat · Action1 hit
01
Slide 1
Eos Energy | Investor Presentation Deck | 24 slidesEos Energy | Investor Presentation Deck | 24 slides · Eos Energy Enterprises
Pitch deck Investor relations Beat · Setup1 hit
02
Eos Energy | Investor Presentation Deck | 24 slidesEos Energy | Investor Presentation Deck | 24 slides · Eos Energy Enterprises
Pitch deck Investor relations Beat · Setup1 hit
03
Eos Energy | Investor Presentation Deck | 24 slidesEos Energy | Investor Presentation Deck | 24 slides · Eos Energy Enterprises
Pitch deck Investor relations Beat · Setup1 hit
04
The slide lists 8 executives with their roles, tenure at Eos, and total years of experience, alongside a grid of logos representing their past/partner organizations.Eos Energy | Investor Presentation Deck | 24 slides · Eos Energy Enterprises
Pitch deck Investor relations Beat · Setup1 hit
05
Uses a funnel-like diagram to structure strategic pillars.Eos Energy | Investor Presentation Deck | 24 slides · Eos Energy Enterprises
Pitch deck Investor relations Beat · WhyLoop · Golden Circle1 hit
06
Uses a funnel diagram to represent market segmentation and Eos's current position relative to the total addressable market.Eos Energy | Investor Presentation Deck | 24 slides · Eos Energy Enterprises
Pitch deck Investor relations Beat · WhyLoop · Golden Circle1 hit
07
The slide uses a table to contrast financial metrics and production strategies, positioning Eos as more efficient than competitors.Eos Energy | Investor Presentation Deck | 24 slides · Eos Energy Enterprises
Pitch deck Investor relations Beat · Problem & ComplicationLoop · Cost Of Inaction1 hit
08
The slide uses a three-pillar strategic framework to organize operational improvements.Eos Energy | Investor Presentation Deck | 24 slides · Eos Energy Enterprises
Pitch deck Investor relations Beat · Problem & ComplicationLoop · Cost Of Inaction1 hit
09
The slide uses a maturity model approach to show product evolution.Eos Energy | Investor Presentation Deck | 24 slides · Eos Energy Enterprises
Pitch deck Investor relations Beat · Problem & ComplicationLoop · Cost Of Inaction1 hit
10
The slide focuses on R&D and Engineering leadership to support the 'Differentiated Technology' claim.Eos Energy | Investor Presentation Deck | 24 slides · Eos Energy Enterprises
Pitch deck Investor relations Beat · Solution & ApproachLoop · Quick Win Big Bet1 hit
11
The slide uses a numbered diagram to map components to the table.Eos Energy | Investor Presentation Deck | 24 slides · Eos Energy Enterprises
Pitch deck Investor relations Beat · Solution & ApproachLoop · Quick Win Big Bet1 hit
12
The slide uses a before-and-after comparison framework to justify the technological advancement of the Eos Z3 battery.Eos Energy | Investor Presentation Deck | 24 slides · Eos Energy Enterprises
Pitch deck Investor relations Beat · Solution & ApproachLoop · Quick Win Big Bet1 hit
13
Uses a combination of SEM imagery for material changes and diagrams for structural/systemic improvements.Eos Energy | Investor Presentation Deck | 24 slides · Eos Energy Enterprises
Pitch deck Investor relations Beat · Solution & ApproachLoop · Quick Win Big Bet1 hit
14
The slide uses a combination of technical diagrams and benefit-driven bullet points to highlight the value proposition of the Z3 product.Eos Energy | Investor Presentation Deck | 24 slides · Eos Energy Enterprises
Pitch deck Investor relations Beat · Solution & ApproachLoop · Quick Win Big Bet1 hit
15
The central diagram is a circular process flow representing the integrated offering.Eos Energy | Investor Presentation Deck | 24 slides · Eos Energy Enterprises
Pitch deck Investor relations Beat · Visualization1 hit
16
Slide features two team members with their tenure and total experience.Eos Energy | Investor Presentation Deck | 24 slides · Eos Energy Enterprises
Pitch deck Investor relations Beat · Visualization1 hit
17
The slide uses a background image of the product (EOS energy storage units) to frame the data blocks.Eos Energy | Investor Presentation Deck | 24 slides · Eos Energy Enterprises
Pitch deck Investor relations Beat · SatisfactionLoop · Voice Of Customer1 hit
18
The slide uses a custom table structure to show how specific technical advantages (RTE, Auxiliary Power, etc.) contribute to a total IRR delta.Eos Energy | Investor Presentation Deck | 24 slides · Eos Energy Enterprises
Pitch deck Investor relations Beat · SatisfactionLoop · Voice Of Customer1 hit
19
The slide features two key finance executives, Jude Lepri and Nathan Kroeker, highlighting their experience.Eos Energy | Investor Presentation Deck | 24 slides · Eos Energy Enterprises
Pitch deck Investor relations Beat · SatisfactionLoop · Voice Of Customer1 hit
20
The chart uses a waterfall structure to show how specific initiatives (R&D, Engineering, Supply Chain, Operations) reduce the cost components (Materials, Labor, Overhead) over time.Eos Energy | Investor Presentation Deck | 24 slides · Eos Energy Enterprises
Pitch deck Investor relations Beat · Action1 hit
21
The slide uses stacked bar charts to detail expense categories and a table for peer benchmarking.Eos Energy | Investor Presentation Deck | 24 slides · Eos Energy Enterprises
Pitch deck Investor relations Beat · Action1 hit
22
Includes a disclaimer about hypothetical scenarios and a project timeline matrix.Eos Energy | Investor Presentation Deck | 24 slides · Eos Energy Enterprises
Pitch deck Investor relations Beat · Action1 hit
23
The slide uses a 2x2 grid for operational metrics and a vertical list for capital updates.Eos Energy | Investor Presentation Deck | 24 slides · Eos Energy Enterprises
Pitch deck Investor relations Beat · Action1 hit
24
Eos Energy | Investor Presentation Deck | 24 slidesEos Energy | Investor Presentation Deck | 24 slides · Eos Energy Enterprises
Pitch deck Investor relations Beat · Action1 hit
01
Slide 1
Equillium | Investor Presentation Deck | 32 slidesEquillium | Investor Presentation Deck | 32 slides · Equillium
Pitch deck Investor relations 1 hit
02
Equillium | Investor Presentation Deck | 32 slidesEquillium | Investor Presentation Deck | 32 slides · Equillium
Pitch deck Investor relations 1 hit
03
The slide uses a hub-and-spoke diagram to centralize the company brand around key investment pillars.Equillium | Investor Presentation Deck | 32 slides · Equillium
Pitch deck Investor relations 1 hit
04
The slide uses a Gantt-style visualization to show clinical trial phases for different drug candidates.Equillium | Investor Presentation Deck | 32 slides · Equillium
Pitch deck Investor relations 1 hit
05
This is a section divider or introductory slide for the product solution.Equillium | Investor Presentation Deck | 32 slides · Equillium
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
06
The slide details a specific corporate partnership agreement.Equillium | Investor Presentation Deck | 32 slides · Equillium
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
07
The slide uses a side-by-side comparison structure to detail the status and upcoming milestones for two distinct clinical programs.Equillium | Investor Presentation Deck | 32 slides · Equillium
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
08
Equillium | Investor Presentation Deck | 32 slidesEquillium | Investor Presentation Deck | 32 slides · Equillium
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
09
Includes a diagram illustrating cytokine-receptor binding and downstream signaling.Equillium | Investor Presentation Deck | 32 slides · Equillium
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
10
The slide uses a visual comparison to frame the problem of current therapeutic limitations.Equillium | Investor Presentation Deck | 32 slides · Equillium
Pitch deck Investor relations Beat · Problem (Identify pain)1 hit
11
The diagram uses a hub-and-spoke model to show how various scientific disciplines feed into the central 'Drug Products' core.Equillium | Investor Presentation Deck | 32 slides · Equillium
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
12
The slide highlights the structural commonality of the γC receptor across multiple cytokines, positioning it as a therapeutic target.Equillium | Investor Presentation Deck | 32 slides · Equillium
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
13
The slide uses a structural biology approach to explain the mechanism of action for their therapeutic platform.Equillium | Investor Presentation Deck | 32 slides · Equillium
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
14
The slide uses a biological process diagram to illustrate how the inhibitor prevents the dimerization of private receptors with the shared receptor.Equillium | Investor Presentation Deck | 32 slides · Equillium
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
15
The slide uses a visual comparison framework to illustrate the mechanism of action and therapeutic benefits.Equillium | Investor Presentation Deck | 32 slides · Equillium
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
16
Equillium | Investor Presentation Deck | 32 slidesEquillium | Investor Presentation Deck | 32 slides · Equillium
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
17
The slide uses a four-column structure to explain the target, molecular nature, preclinical results, and clinical status.Equillium | Investor Presentation Deck | 32 slides · Equillium
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
18
The slide uses a column-based layout to compare four distinct medical conditions, each with specific patient counts and development milestones.Equillium | Investor Presentation Deck | 32 slides · Equillium
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
19
The slide uses Western blot data to visually demonstrate the efficacy of EQ101 compared to a standard JAK inhibitor.Equillium | Investor Presentation Deck | 32 slides · Equillium
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
20
Includes before/after patient photos and comparative data against Mogamulizumab.Equillium | Investor Presentation Deck | 32 slides · Equillium
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
21
Equillium | Investor Presentation Deck | 32 slidesEquillium | Investor Presentation Deck | 32 slides · Equillium
Pitch deck Investor relations Beat · Solution (Provide relief)Loop · Quick Win Big Bet1 hit
22
The slide uses a circular process diagram to show the feedback loop of cytokines and immune cells leading to hair loss.Equillium | Investor Presentation Deck | 32 slides · Equillium
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
23
Includes visual longitudinal data (photos) and quantitative bar chart data.Equillium | Investor Presentation Deck | 32 slides · Equillium
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
24
The slide compares two different drugs (baricitinib and deuruxolitinib) using their respective clinical trial data (BRAVE AA1 and THRIVE AA1).Equillium | Investor Presentation Deck | 32 slides · Equillium
Pitch deck Investor relations 1 hit
25
Includes a blackbox warning text block as a competitive/safety barrier context.Equillium | Investor Presentation Deck | 32 slides · Equillium
Pitch deck Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit